Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.038; wR factor = 0.102; data-to-parameter ratio = 23.5.
In the title compound, C 24 H 22 BrNO 3 , the dihydropyran ring adopts a half-chair conformation, whereas the pyrrolidine ring is in an envelope conformation. The bromophenyl group is oriented at an angle of 66.44 (4) with respect to the naphthalene ring system. In the crystal structure, molecules are linked into centrosymmetric dimers by C-HÁ Á Á interactions and the dimers are connected via C-HÁ Á ÁBr hydrogen bonds. The crystal structure is further stabilized byinteractions [centroid-centroid distance = 3.453 (1) Å ].
Related literature
For the biological activity of pyrrole derivatives, see: Biava et al. (2005) ; Borthwick et al. (2000) ; Caine (1993); Carlson (1993); Fernandes et al. (2004); Jiang et al. (2004) ; Sokoloff et al. (1990) ; Tidey (1992) ; Wilner (1985) . For a related structure, see: Nirmala et al. (2009) . For ring-puckering parameters, see: Cremer & Pople (1975) .
Experimental
Crystal data 
Data collection
Bruker Kappa APEXII areadetector diffractometer Absorption correction: multi-scan (Blessing, 1995 Table 1 Hydrogen-bond geometry (Å , ). (Caine, 1993) , aggressiveness (Tidey, 1992 ), parkinson's disease (Carlson, 1993) , psychoses, memory disorders (Sokoloff et al., 1990) , anxiety and depression (Wilner, 1985) . Pyrrole derivatives have good in vitro activities against mycobacteria and candidae (Biava et al., 2005) . These derivatives also possess anti-inflammatory (Fernandes et al., 2004) and antiviral (Borthwick et al., 2000) activities. It has also been shown that N-substituted pyrrole derivatives inhibit human immuno deficiency virus type-I (HIV-I) (Jiang et al., 2004) . In view of its medicinal importance, the crystal structure determination of the title compound was undertaken.
The geometric parameters of the title molecule ( Fig. 1 ) agree well with those reported for a similar structure (Nirmala et al., 2009) The crystal packing is stabilized by intermolecular C-H···Br hydrogen bonds. The molecules are linked into centrosymmetric dimers by C-H···π (C20-H20···Cg1; Cg1 is the centroid of the C3-C8 ring) interactions (Table 1 ). In addition, π-π interactions between C3-C8 rings at (x, y, z) and (2 -x, 1 -y, 2 -z) stabilize the structure, with a centroid-to-centroid distance of 3.453 (1) Å.
Experimental
A mixture of (Z)-methyl 2-((1-formylnaphthalen-2-yloxy)methyl)-3-(4-bromophenyl)acrylate (20 mmol) and sarcosine (30 mmol) were refluxed in benzene for 20 h and the solvent was removed under reduced pressure. The crude product was subjected to column chromatography to get the pure product. Chloroform and methanol (1:1) solvent mixture was used for the crystallization under slow evaporation method.
Refinement
H atoms were placed in idealized positions and allowed to ride on their parent atoms, with C-H = 0.93, 0.98, 0.97 and 0.96 Å for aromatic, methine, methylene and methyl H respectively, and U iso (H) = 1.5U eq (C) for methyl H and U iso (H) = 1.2U eq (C) for all other H atoms. Reflections 110 and 100 were omitted during the final cycles of refinement since they were seriously effected by the beamstop.
supplementary materials sup-2 Figures   Fig. 1 . The molecular structure of the title compound, with 30% probability displacement ellipsoids. 
